NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4,060.69 mln
Float188 mln
Earnings Date11/11/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.66
Likely reliable
1-Year Forecast
27.08
Exceptional upside
Relative Strength
30
/ 100
Underperforming
Debt / Equity
0.03
Debt-free
Pre-Tax Margin
-2,764%
Severely loss-making
Business Description
Relay Therapeutics is a Cambridge, Massachusetts-based clinical-stage company focused on discovering new drugs to treat certain cancers and genetic diseases. Its main drug candidates target breast cancer, solid tumors, vascular malformations, and Fabry disease, with additional programs aimed at key cancer-driving proteins. The company works with partners including Pfizer, Elevar Therapeutics, and D. E. Shaw Research, using advanced computer modeling of protein behavior to guide its drug development efforts.
